发明名称 |
Compositions of Glycopyrronium Salt for Inhalation |
摘要 |
A process for preparing dry powder formulations of a glycopyrronium salt for inhalation that have good stability. The process involves (a) micronising a glycopyrronium salt together with an anti-adherent agent, and (b) admixing carrier particles to form the dry powder formulation. |
申请公布号 |
US2016081934(A1) |
申请公布日期 |
2016.03.24 |
申请号 |
US201514960472 |
申请日期 |
2015.12.07 |
申请人 |
Haeberlin Barbara;Stowasser Frank;Wirth Wolfgang;Baumberger Anton;Abel Stephen;Kaerger Sebastian;Kieckbusch Thomas |
发明人 |
Haeberlin Barbara;Stowasser Frank;Wirth Wolfgang;Baumberger Anton;Abel Stephen;Kaerger Sebastian;Kieckbusch Thomas |
分类号 |
A61K9/16;A61K31/40;A61K45/06;A61K9/00 |
主分类号 |
A61K9/16 |
代理机构 |
|
代理人 |
|
主权项 |
1. A process for preparing a dry powder formulation of a glycopyrronium salt for inhalation that comprises the steps of (a) mixing a glycopyrronium salt and to 5% by mass of magnesium stearate, based on the total amount of glycopyrronium salt and magnesium stearate, to give a homogeneous blend; (b) micronising the blend; and (c) admixing carrier particles to the micronized blend to form a dry powder formulation, wherein the carrier particles are mixed with the blend of micronized glycopyrronium salt and magnesium stearate in a ratio of 200:1 to 20:1 by mass. |
地址 |
Munchenstein CH |